Novel and Emerging Chemotherapeutic Agents in Head and Neck Cancer

Despite the advancements in the treatment of squamous head and neck cancer in the past decade, clinical outcomes still remain poor. The use of multimodality treatment and the advent of targeted therapies have improved outcomes. This chapter will provide a brief overview of the current management for squamous head and neck cancers in both the locally advanced and metastatic settings. We will then outline targeted therapies currently in use or under investigation for the treatment of both locally advanced and metastatic head and neck cancer.